BIO 2023: A Showcase of Creative Biolabs’ Excellence and Innovation

June 09 20:30 2023
Creative Biolabs released exhibition highlight moments at booth 2548 during the 2023 BIO International Convention in Boston from June 5 to 8.

New York, USA – June 9, 2023 – The BIO International Convention, the world’s largest biotechnology event, is returning to Boston from June 5-8, 2023. Among the thousands of exhibitors, Creative Biolabs, a leading provider of biotechnology solutions, is once again participating in this grand gathering of the biotech industry. A team of experienced scientists from Creative Biolabs is presenting their pivot products and services at booth 2548 and engaging with potential partners and customers from around the globe.

“This is a fantastic event for the biotech industry, providing a great opportunity to meet with other professionals, learn about the latest innovations and trends, and showcase our products and services. I’m very excited to be here and to share our achievements and vision with the world,” according to a senior scientist at Creative Biolabs. “Our exhibition this year features innovation in biotechnology to improve drug discovery. We have received positive feedback and interest from many potential partners and customers who visited our booth. We also had fruitful discussions and networking opportunities with other industry leaders and experts during the event.”

With the aim of improving innovative therapeutic solutions towards precision medicine, Creative Biolabs initiated its antibody discovery solutions as a startup, offering a series of technical schemes, such as phage display library construction and screening, hybridoma services, single domain antibody discovery, native antibody discovery, premade antibody libraries, de novo antibody sequencing, antibody humanization, affinity maturation, and post-translational modification specific antibody discovery.

“One of our solutions that is attracting the partners’ attention is de novo antibody sequencing,” added the scientist.

Based on its proprietary Database Assisted Shotgun Sequencing (DASS) technology, the unique de novo sequencing scheme covers both single domain antibodies (sdAbs) and conventional antibodies and can reach 100% accuracy of differentiation between leucine and isoleucine, solving a long-standing problem in antibody sequencing.

“I think the future is very bright for the biotechnology industry. We are witnessing rapid advances in science and technology that enable us to tackle some of the most challenging diseases and unmet medical needs. For example, we are developing novel platforms for engineering antibody conjugates to combat antibiotic-resistant infections. We are also exploring the potential of exosomes to deliver drugs or biomolecules to specific targets. These are just some examples of how we are harnessing the power of biotechnology to create innovative and effective therapies,” added the scientist. “Affairs like BIO 2023 provide great opportunities for us to showcase our progress, as well as to learn from and collaborate with other players in the field. We hope to see you in our forthcoming exhibitions!”

Learn more about Creative Biolabs’ event arrangements:


Creative Biolabs is a world-class provider of custom biotech and pharmaceutical services for drug discovery and development. For over a decade, Creative Biolabs has delivered hundreds of projects to global clients, from academia to industry. By offering first-rate services such as antibody discovery and engineering, bio-manufacturing, recombinant antibodies, single domain antibodies, biosimilars, and mRNA therapeutics, Creative Biolabs strives to advance the next discovery for every vision and every solution.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States